This is the online edition of Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox.
Here we go again: My ‘JPM Week’ preview
Starting Sunday, the biopharma world descends on San Francisco for a nonstop week of public and private company presentations, closed-door business meetings, networking schmooze-a-thons, fancy dinners, and late-night cocktail parties.
“JPM Week” is an indispensable January pilgrimage for the biopharma tribe where news is made — sources gab — and deals get done. It’s also a bloated biotech bacchanalia that rarely justifies the expense or lives up to the hype.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? Log in